CNTA
CentessaBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
Current thesis
The bull case is now mostly merger-arb: the stock closed at $39.60 on May 14, 2026 versus $38.00 cash plus CVR consideration, and the Q1 2026 filing did not introduce a balance-sheet problem that obviously threatens the pending transaction. If the June 12 meetings progress cleanly and closing risk keeps compressing, the market can continue to carry value above the cash leg for expected CVR optionality.
Posture
Constructive
Lead driver
Momentum
What changed
2 setup hits (3d) with net bearish as of 2026-06-01.
What can break
If the transaction is terminated under specified circumstances, Centessa could owe Lilly an approximately $63 million termination fee, adding downside if the process breaks [#10-Q-2026-05-05].
Momentum
84
Value
41
Sentiment
45
Setup hits (3d)
2 · Net Bearish
AI TargetsBase $39.80 · Bull $42.00 · Bear $30.00
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-05-29 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-15 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-06-02
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Bearish
Target $40.38
Why
Momentum84 · Δ7d -5.5
Value41 · Δ7d +0.1
Sentiment45 · Δ7d +3.0
So what
Strength-led posture (Net Bearish). Favor watchlist adds and disciplined entries.
Lead driver: Momentum · See technicals
Momentum
84
34% active weight
Current posture
7d trendSoftening
Δ7d
-5.5
Δ21d
-9.3
Value
41
32% active weight
Current posture
7d trendFlat
Δ7d
+0.1
Δ21d
+0.2
Sentiment
45
33% active weight
Current posture
7d trendImproving
Δ7d
+3.0
Δ21d
+8.0
Why this grade
Composite grade B. Momentum 84.4 / Value 41.1 / Sentiment 44.9
Fundamentals (TTM)As of 2026-05-29
Fundamentals (TTM)
As of 2026-05-29
Market Cap
$6.15B
Beta
1.57
Shares Out
134.45M
P/E (TTM) · Derived
-26.0
P/S (TTM)
224.14
P/FCF (TTM) · Derived
-33.68
Rev YoY
-100.0%
EPS YoY
-11.7%
Gross Margin
-
Op Margin
-1652.6%
Net Debt
-$373.24M
Current Ratio
10.56
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology